This fall and winter, Ontario, Quebec and Nunavut will offer nirsevimab — approved by Health Canada in the spring of 2023 — to all babies going through their first RSV season.
Amid measles outbreak, some Ontario public health units recommending vaccine for some babies at younger age
- today, 9:12 PM
- cbc.ca
- 0
No comments